Cytokinetics (CYTK) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to -$66.9 million.
- Cytokinetics' Free Cash Flow rose 977.41% to -$66.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$399.8 million, marking a year-over-year increase of 383.48%. This contributed to the annual value of -$399.8 million for FY2024, which is 383.48% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Free Cash Flow is -$66.9 million, which was up 977.41% from -$102.2 million recorded in Q3 2024.
- Cytokinetics' Free Cash Flow's 5-year high stood at $45.6 million during Q4 2020, with a 5-year trough of -$131.3 million in Q1 2024.
- In the last 5 years, Cytokinetics' Free Cash Flow had a median value of -$70.5 million in 2023 and averaged -$66.0 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 32393.3% in 2020, then tumbled by 56259.02% in 2021.
- Cytokinetics' Free Cash Flow (Quarter) stood at $45.6 million in 2020, then tumbled by 237.06% to -$62.5 million in 2021, then tumbled by 62.26% to -$101.4 million in 2022, then increased by 26.91% to -$74.1 million in 2023, then increased by 9.77% to -$66.9 million in 2024.
- Its last three reported values are -$66.9 million in Q4 2024, -$102.2 million for Q3 2024, and -$99.5 million during Q2 2024.